gene for Crohn's disease
Alterations in the receptor for a known inflammatory response pathway are strongly associated with Crohn's disease and ulcerative colitis, according to a report by a consortium of American and Canadian researchers in the Oct. 26 online Science Express.
Crohn's disease and ulcerative colitis -- collectively called inflammatory bowel disease (IBD) -- are chronic disorders that cause abdominal pain, diarrhea and gastrointestinal bleeding; they affect over one million Americans. Because IBD tends to run in families and is more frequent in certain ethnic populations, especially Ashkenazi Jews, scientists have long suspected a significant genetic component.
According to senior author Dr. Judy H. Cho, associate professor in the Departments of Medicine and Genetics at the School of Medicine, the team found that mutations in a receptor gene associated with the interleukin-23 (IL-23) pathway, are linked to Crohn's disease. The IL-23 pathway is known to target organ-specific inflammatory responses.
"This finding is particularly intriguing because we appear to have identified a gene variant that protects against development of IBD," says Cho, who also directs the Inflammatory Bowel Disease Center at Yale. "It causes us to think about the genetics of health as well as about the genetics of the disease. One mutation appears to offer significant protection from IBD and will be a crucial target for drugs that might better manage Crohn's disease and ulcerative colitis."
Previous genetic studies found a link between Crohn's disease and mutations in a gene known as CARD 15, but those mutations alone did not account for all of the genetic components of the disease.
To identify additional genes associated with IBD, the international research team scanned the genome, testing more than 300,000 single nucleotide polymorphisms (or SNPs) in people with Crohn's disease. They compared results with the SNPs in a similar number of people without IBD. In addition to two differences in the CARD 15 gene, they found a third variant SNP, which was in a different gene on a different chromosome -- the IL-23 receptor.
"We know that the IL-23 receptor plays an important role in activating inflammation, including in organs of the digestive tract, therefore it could be an extremely important target for improving the management of Crohn's disease and ulcerative colitis," says Cho. "However, the IL-23 pathway may serve a useful purpose in protecting us from other diseases, so when seeking to block or manipulate its activity with drugs or other means, we need to take this balancing act into consideration."
Cho and co-authors represent the IBD Genetics Consortium, which is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH). Cho says the large study sizes made possible by the consortium offer more definitive conclusions.
Dr. Stephen P. James, director of the Division of Digestive Diseases and Nutrition at the National Institutes of Health's NIDDK, notes: "This important discovery not only offers new hope for better therapies for patients with Crohn's disease, it also highlights the promise of the human genome project and subsequent investments by the NIH in large-scale, collaborative research projects to unravel the causes of, and hopefully find better treatments for complex, enigmatic diseases."
The consortium's member institutions include Cedars-Sinai Medical Center in Los Angeles, the University of Chicago, Johns Hopkins University, Université de Montréal, the University of Pittsburgh, the University of Toronto and the Yale School of Medicine.
-- By Karen Peart
T H I S
W E E K ' SS T O R I E S
Yale expanding nanoscience, quantum engineering focus
New York Times editor to teach journalism course
Spinal cord research of special interest to veterans group
Law librarian took the words right out of their mouths
Yale research team identifies gene for Crohn's disease
ENDOWED PROFESSORSHIPS
Nicholas Barberis is named Schramm Professor of Finance at SOM
Christine Jolls is appointed the Gordon Bradford Tweedy Professor
Kenji Yoshino is designated . . . first Guido Calabresi Professor of Law
Two investigators win grants for research on women's health issues
Posters showcase work on women and gender
Conference exploring the impact of dams . . .
Journal's special issue focuses on most environmentally harmful products
Lectures will examine the reasons for humans' love of music
Scientists to discuss their work 'Panning for Gold
Seminar to focus on company's genome sequencing technology
Event will showcase cultural dances from around the world
Guitar festival will include performances and master classes
Campus Notes
Bulletin Home|Visiting on Campus|Calendar of Events|In the News
Bulletin Board|Classified Ads|Search Archives|Deadlines
Bulletin Staff|Public Affairs|News Releases|
E-Mail Us|Yale Home